The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 30, 2020

Filed:

Sep. 11, 2017
Applicants:

Siec Badawcza Lukasiewicz—instytut Biotechnologii I Antybiotykow, Warsaw, PL;

Uniwersytet Gdański, Gdańsk, PL;

Inventors:

Violetta Sączyńska, Warsaw, PL;

Violetta Cecuda-Adamczewska, Warsaw, PL;

Anna Porębska, Warsaw, PL;

Katarzyna Florys, Warsaw, PL;

Anna Bierczyńska-Krzysik, Warsaw, PL;

Piotr Baran, Warsaw, PL;

Agnieszka Romanik-Chruścielewska, Jozefow, PL;

Grażyna Płucienniczak, Warsaw, PL;

Andrzej Płucienniczak, Warsaw, PL;

Piotr Borowicz, Warsaw, PL;

Krzysztof Kucharczyk, Warsaw, PL;

Boguslaw Szewczyk, Gdansk, PL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/005 (2006.01); C07K 16/10 (2006.01); G01N 33/569 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1018 (2013.01); C07K 14/005 (2013.01); G01N 33/56983 (2013.01); C07K 2317/33 (2013.01); C07K 2317/52 (2013.01); C07K 2317/55 (2013.01); C07K 2317/76 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01); G01N 2333/11 (2013.01);
Abstract

The object of the invention are monoclonal antibodies against hemagglutinin of H5-serotype influenza viruses selected from the group comprising G-1-31-22, G-2-14-10, G-5-32-5, G-6-42-42, G-7-24-17 and G-7-27-18, having a broad application in immunoprophylaxis and immunotherapy of infections evoked by H5-serotype influenza viruses in humans and animals. The invention also provides hybridomas producing said antibodies, as well as compositions and diagnostic kits containing said antibodies for the detection and typing of H5-serotype influenza viruses and antibodies against H5-serotype influenza viruses in biological samples.


Find Patent Forward Citations

Loading…